Why this matters: injectable GLP-1s like semaglutide and tirzepatide achieve 15 to 20% weight reductions, but injections, cost, and adherence limit real-world use (Santulli review, Journal of Diabetes & Metabolic Disorders, 2025)
The good news is that these usually occur during the "dose escalation" phase and subside as the body adapts
A real-world study with 769 Korean people with obesity, body weight and BMI decreased significantly after initiation of liraglutide 3.0 mg treatment: 2.94 kg and 1.08 kg/m 2 at 2 months
Both countries have built massive peptide manufacturing infrastructure over the years, and semaglutide is no exception
Studies demonstrate that butyrate stimulates mucin production, creating a thicker, more protective coating that helps maintain digestive comfort and supports normal bowel function